NCT03615599Active, not recruiting
Plant-based Diets and Risk of Cancer in the Adventist Health Study-2
Cancer Epidemiology in Seventh-day Adventists
Source: ClinicalTrials.gov · Last updated 30 Jan 2026
Brief summary (registry, in English)
The Adventist Health Study-2 is a long-term study, exploring the links between lifestyle, diet, and disease outcomes among Seventh-day Adventists. More than 96,000 church members from the U.S. and Canada are participating in the current study, AHS-2, conducted by researchers at the Loma Linda University School of Public Health.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 96000 (actual)
- First submitted
- 29 Jun 2018
- Start date
- 1 Feb 2002
- Primary completion date
- 31 Dec 2013
- Lead sponsor
- Loma Linda University
- Diseases
- Prostate cancer, Colorectal cancer
- NCT number
- NCT03615599
What you commit to
- Study type: Observational
- Participants enrolled: 96000
- From 1 Feb 2002 to the primary completion date, 31 Dec 2013
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Less than 30 years of age
Other
- Church members who did not complete the baseline questionnaire.
- Incarcerated or institutionalized people
- Non-English speakers
Who the study is looking for
- Member of a Seventh-day Adventist church \>30 years of age Ability to read English Live in the US or Canada
Age in the registry: 30 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Loma Linda University Coordinator of this site? Confirm its status | Loma Linda | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.